Literature DB >> 7518599

Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.

Y Hasui1, K Marutsuka, Y Asada, H Ide, S Nishi, Y Osada.   

Abstract

The relationship between the serum values of prostate specific antigen (PSA) and the extent of histological prostatitis was investigated in 42 patients undergoing transurethral resection of the prostate for benign hyperplasia (BPH) without clinical evidence of prostatitis. Histological prostatitis was divided into three groups: acute, chronic-active, and chronic-inactive inflammation. The extent of histological prostatitis was expressed as the number of prostatic acinar and ductal glands with inflammatory infiltrate per total number of glands (%). The serum PSA values significantly correlated with the extent of acute and chronic-active prostatitis (correlation coefficient r = 0.765 and 0.656, P < 0.01). A relationship between PSA values and the extent of chronic-inactive prostatitis was not found. In the immunohistochemical study, prostatic epithelial cells with acute and chronic-active inflammation showed negative staining for PSA antigen. These results indicate that histological acute and chronic-active prostatitis is considered an important factor for inducing the high increase in serum PSA values via the leak phenomenon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518599     DOI: 10.1002/pros.2990250206

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  23 in total

1.  The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis.

Authors:  Cuneyt Ozden; Ozdem Levent Ozdal; Ozer Guzel; Ozge Han; Selda Seckin; Ali Memis
Journal:  Int Urol Nephrol       Date:  2006-11-17       Impact factor: 2.370

Review 2.  Strategies for repeat prostate biopsies.

Authors:  Martha K Terris
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

Review 3.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

4.  Prostate specific antigen in urinary tract infection.

Authors:  C R Bell; S Natale; P D McInerney; J C Hammonds
Journal:  Br J Gen Pract       Date:  1998-02       Impact factor: 5.386

5.  Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men.

Authors:  J T Anim; E O Kehinde; A Prasad; M Sheikh; O A Mojiminiyi; Y Ali; K Al-Awadi
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

6.  Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin.

Authors:  P D Walden; G K Lefkowitz; M Ittmann; H Lepor; M E Monaco
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

7.  Does asymptomatic inflammation increase PSA? A histopathological study comparing benign and malignant tissue biopsy specimens.

Authors:  B H Gümüş; N Neşe; M I Gündüz; A R Kandiloglu; Y Ceylan; C Büyüksu
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

8.  A prospective study of reducing unnecessary prostate biopsy in patients with high serum prostate-specific antigen with consideration of prostatic inflammation.

Authors:  An Gu Lee; Yong Hyeuk Choi; Sung Yong Cho; In Rae Cho
Journal:  Korean J Urol       Date:  2012-01-25

9.  Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey.

Authors:  Alicia C McDonald; Manish A Vira; Adriana C Vidal; Wenqi Gan; Stephen J Freedland; Emanuela Taioli
Journal:  Prostate       Date:  2014-01-16       Impact factor: 4.104

10.  Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer.

Authors:  Ichiya Honma; Toshihiko Torigoe; Yoshihiko Hirohashi; Hiroshi Kitamura; Eiji Sato; Naoya Masumori; Yasuaki Tamura; Taiji Tsukamoto; Noriyuki Sato
Journal:  J Transl Med       Date:  2009-12-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.